King Faisal Specialist Hospital & Research Centre Holds Firm as Global and Regional Healthcare Leader

Udgivet den 15-02-2024  |  kl. 11:03  |  


RIYADH, Saudi Arabia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSH&RC) has once again secured its position for the second consecutive year as a global leader in healthcare and number one in the Middle East and Africa, ranking 20th globally among the leading healthcare institutions in the Brand Finance Global Top 250 Hospitals 2024 report. KFSH&RC continues to stand at the forefront both locally and regionally, underlining its commitment to delivering world-class patient-centric healthcare and medical innovation.

Leading the way, KFSH&RC is joined by King Saud Medical City, King Khalid University Hospital, National Guard Health Affairs, and King Fahd Medical City, all ranked among the top 100 globally. While King Fahd University Hospital and King Abdullah Medical City rank between 101 and 250. This assessment is based on insights from thousands of healthcare practitioners across over 30 countries.

The remarkable performance of KFSH&RC in this global ranking is a testament to the Kingdom's healthcare transformation goals and the transformative impact of Vision 2030, reflected through the continuous improvement of healthcare services and the pursuit of technological advancements across the Kingdom for a healthier and thriving nation.

Brand Finance, founded in 1996, annually evaluates over 500 hospitals worldwide, utilizing more than 30 performance indicators encompassing healthcare, research centres, and education to support science-based strategic decision making.

King Faisal Specialist Hospital & Research Centre stands among the global leaders in providing specialized healthcare, driving innovation, and serving as an advanced hub for medical research and education. Through strategic partnerships with prominent local, regional, and international institutions, the hospital is dedicated to advancing medical technologies and elevating the standards of healthcare worldwide.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, Brand Finance ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally. Additionally, in 2022, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non-profit, government-owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1cab7add-5d3e-482c-bd5b-cc8856cf7875


\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

17:52 Europa/lukning: Trumps toldvarsel gav trykket fredagsstemning
17:15 Fredagens obligationer: Marginale rentefald præget af Trumps toldvarsler og inflationstal
17:14 Fredagens aktier: Teknisk fremgang til Novonesis mens Trump lagde låg på stemningen
15:46 USA/åbning: Nvidia atter under pres i let rød start
15:40 Nye inflationstal baner vej for rentenedsættelse i ECB - kan ske allerede torsdag
15:03 Tørlastindeks fortsætter grøn stime med 12. dag med plus
14:25 USA/tendens: Inflationstal tager fokus inden ventet grøn start
13:24 Greenmobilitys strategiskifte gav pote i 2024: Mere vækst venter i 2025
13:09 Trump er ved at miste grebet om Wall Street: Investorer vil snart håbe på indgreb
13:05 Gubra-aktien ramt af mindre fokus på succesfuld kontraktforretning vurderer Kempen
12:59 Skakos finansdirektør takker af efter knap tre år
12:58 Europa/aktier: Trumps toldvarsel giver trykket fredagsstemning
12:19 Obligationer/middag: Små rentefald præget af Trumps toldtrusler
11:51 Aktier/middag: Småsur fredagstemning med teknisk fokus på Novonesis og Coloplast
11:40 Europæiske inflationstal til den lave side presser renterne lidt ned
11:35 Gubra sendes til tælling efter årsregnskab
10:53 GN nærmer sig laveste niveau siden 2023 på Trumps toldtrusler
09:23 Aktier/åbning: Mærsk går til bunds oven på de seneste toldtrusler fra Trump
09:17 Aarsleff-aktien falder 7 pct. efter regnskab: Indtjeningen skuffer analytikerne
08:53 Obligationer/åbning: Investorerne søger i ly for Trumps toldtrusler - renten falder